First case of mirtazepine-induced Stevens-Johnson syndrome from India | Zendy

Amit Bhasin | Zendy; Anil Gurtoo | Zendy; Latika Gupta | Zendy; Gunjan Aggarwal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

First case of mirtazepine-induced Stevens-Johnson syndrome from India

Author(s) -

Amit Bhasin,

Anil Gurtoo,

Latika Gupta,

Gunjan Aggarwal

Publication year - 2012

Publication title -

indian journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.286

H-Index - 59

eISSN - 1998-3751

pISSN - 0253-7613

DOI - 10.4103/0253-7613.100411

Subject(s) - mucocutaneous zone , dermatology , medicine , exacerbation , lupus erythematosus , overlap syndrome , blisters , adverse effect , pathology , immunology , disease , antibody

A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research